Medicare plans are replacing brand-name buprenorphine-naloxone film with its generic equivalents, resulting in a decrease in out-of-pocket cost faced by enrollees with opioid use disorder. Objectives: ...

(Reuters) - A divided federal appeals court on Friday ruled against Indivior Plc in its bid to stop Dr. Reddy's Laboratories Ltd and Alvogen from selling generic versions of its opioid addiction ...

Indivior, a pharmaceutical company, has reached a $30 million settlement to resolve a class action lawsuit filed in a U.S. court by health plans. The lawsuit alleges that the company unlawfully ...

The US Food and Drug Administration (FDA) has approved the first generic versions of Suboxone (buprenorphine and naloxone) sublingual film for the treatment of opioid dependence, which may increase ...

(Reuters) - Indivior's U.S. subsidiary has filed lawsuits against firms seeking approval for generic versions of its opioid addiction treatment Suboxone, which generates 80 percent of the drugmaker's ...

Dr. Reddy’s Laboratories, a generic drug maker with U.S. headquarters in Princeton Junction, has won U.S. Food and Drug Administration approval to sell a generic version of Suboxone sublingual film, a ...

For young people with opioid use disorder (OUD), buprenorphine costs have declined overall but with drastic variation by payer type, researchers found. Examining buprenorphine prescriptions dispensed ...

(Reuters) - Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its ...

The Wisconsin Department of Justice along with 40 other states and the District of Columbia has settled a lawsuit for $102.5 million against the makers of anti-opioid addiction drug Suboxone for what ...

PHILADELPHIA (AP) — The company that makes the opioid addiction treatment drug Suboxone has agreed to pay $102.5 million to 41 states and the District of Columbia to settle claims that the company ...

Medicare Part D or Part C plans with drug coverage may cover Suboxone, a medication used to treat opioid use disorder (OUD). If you receive the drug as an inpatient or in a clinic with the help of a ...

Twenty-four percent of US adolescent treatment centers do not use a “lifesaving” medication. An article appeared today in the Journal of the American Medical Association titled “Treatments Used Among ...